President Trump announced a deal with UK drug manufacturer AstraZeneca on Oct. 10. The pharmaceutical company will have a new drug pricing model on the government's platform dubbed "TrumpRx," which will include more affordable prices. Trump also said the company will also invest $50 billion in US research, development, and drug manufacturing.

See Full Page